CTRE:NYE-CareTrust REIT Inc. (USD)

COMMON STOCK | REIT - Healthcare Facilities |

Last Closing

USD 30.88

Change

0.00 (0.00)%

Market Cap

USD 4.66B

Volume

0.81M

Analyst Target

USD 18.67
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

CareTrust REIT, Inc.'s ("CareTrust REIT" or the "Company") primary business consists of acquiring, financing, developing and owning real property to be leased to third-party tenants in the healthcare sector. As of March 31, 2024, the Company owned directly or through a joint venture and leased to independent operators, 228 skilled nursing facilities ("SNFs"), multi-service campuses, assisted living facilities ("ALFs") and independent living facilities ("ILFs") consisting of 24,189 operational beds and units located in 29 states with the highest concentration of properties by rental income located in California and Texas. As of March 31, 2024, the Company also had other real estate related investments consisting of one preferred equity investment, nine real estate secured loans receivable and four mezzanine loans receivable with a carrying value of $233.3 million.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-10-20 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

N/A

USD 80.86B
VTR Ventas Inc

N/A

USD 27.19B
DOC Healthpeak Properties Inc

N/A

USD 15.83B
AHR American Healthcare REIT, Inc.

N/A

USD 3.85B
NHI National Health Investors Inc

N/A

USD 3.33B
LTC LTC Properties Inc

N/A

USD 1.57B
UHT Universal Health Realty Income..

N/A

USD 0.58B
CHCT Community Healthcare Trust Inc

N/A

USD 0.50B
GMRE-PA Global Medical REIT Inc

N/A

USD 0.41B
OHI Omega Healthcare Investors Inc

N/A

N/A

ETFs Containing CTRE

FCII:CA Franklin ClearBridge Sust.. 5.06 % 0.00 %

N/A

CAD 0.02B
CINF:CA CI Global Infrastructure .. 4.66 % 0.00 %

N/A

CAD 0.28B
HDLV 3.31 % 0.00 %

N/A

N/A
XLUY 3.00 % 0.00 %

N/A

N/A
CZA Invesco Zacks Mid-Cap ETF 1.84 % 0.65 %

N/A

N/A
TPHE Timothy Plan - Timothy Pl.. 1.39 % 0.00 %

N/A

USD 0.07B
PSCF Invesco S&P SmallCap Fina.. 1.31 % 0.29 %

N/A

USD 0.02B
CDC VictoryShares US EQ Incom.. 1.28 % 0.35 %

N/A

USD 0.84B
XSLV Invesco S&P SmallCap Low .. 1.14 % 0.25 %

N/A

USD 0.32B
ENG:PA BNP Paribas EASY ECPI Glo.. 1.13 % 0.00 %

N/A

USD 0.23B
XU61:F BNP Paribas Easy SICAV - .. 1.13 % 0.00 %

N/A

USD 0.24B
DIVA 1.07 % 1.00 %

N/A

N/A
ULOV:LSE 0.72 % 0.00 %

N/A

N/A
USVM VictoryShares US Small Mi.. 0.63 % 0.25 %

N/A

USD 0.28B
FTGU:F First Trust Global Funds .. 0.51 % 0.00 %

N/A

N/A
FTGU:XETRA First Trust US Large Cap .. 0.51 % 0.00 %

N/A

USD 0.10B
FXU First Trust Utilities Alp.. 0.00 % 0.63 %

N/A

N/A
HSMV First Trust Horizon Manag.. 0.00 % 0.00 %

N/A

USD 0.02B

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 37.98% 79% B- 87% B+
Dividend Return N/A N/A N/A N/A N/A
Total Return 37.98% 79% B- 87% B+
Trailing 12 Months  
Capital Gain 42.76% 64% D 80% B-
Dividend Return N/A N/A N/A N/A N/A
Total Return 42.76% 64% D 81% B-
Trailing 5 Years  
Capital Gain 29.15% 92% A 65% D
Dividend Return N/A N/A N/A N/A N/A
Total Return 29.15% 92% A 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 9.00% 86% B+ 65% D
Dividend Return 14.27% 93% A 72% C
Total Return 5.27% 43% F 83% B
Risk Return Profile  
Volatility (Standard Deviation) 22.61% 57% F 46% F
Risk Adjusted Return 63.13% 86% B+ 79% B-
Market Capitalization 4.66B 70% C- 77% C+

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.